fda cleared cloud based software platform (Cleerly Inc)
Structured Review
Fda Cleared Cloud Based Software Platform, supplied by Cleerly Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cloud+software/based+deep+learning+platform+software+validated/pm41421030-194-0-4
Average 86 stars, based on 1 article reviews
Images
Related Articles
Software:Article Title: Artificial intelligence in modern clinical practice (Review) Article Snippet: .. With automated analysis by a software Article Title: The time-varying prognostic value of stenosis and plaque burden in coronary artery disease Article Snippet: .. A US Food and Drug Administration-approved artificial Article Title: Diagnostic Performance of AI-Assisted Coronary CT Angiography: A Systematic Review and Meta-Analysis. Article Snippet: .. Article Title: Health Plan-Based Atherosclerosis Imaging for Members with Diabetics: Utilization and Impact on Subsequent Episodes of Care. Article Snippet: All CCTA acquisitions were performed on scanners with 128 detector rows (Siemens Healthcare) per standard practice. .. CCTA images were then analyzed with Article Title: Health Plan-Based Atherosclerosis Imaging for Members with Diabetics Article Snippet: All CCTA acquisitions were performed on scanners with 128 detector rows (Siemens Healthcare) per standard practice. .. CCTA images were then analyzed with Computed Tomography:Article Title: Pericoronary adipose tissue as a biomarker of coronary atherosclerosis and cardiovascular risk in rheumatoid arthritis Article Snippet: .. Quantitative assessments used the Article Title: The time-varying prognostic value of stenosis and plaque burden in coronary artery disease Article Snippet: .. A US Food and Drug Administration-approved artificial Article Title: Pericoronary adipose tissue as a biomarker of coronary atherosclerosis and cardiovascular risk in rheumatoid arthritis. Article Snippet: .. Quantitative assessments used the Food & Beverages:Article Title: The time-varying prognostic value of stenosis and plaque burden in coronary artery disease Article Snippet: .. A US Food and Drug Administration-approved artificial Imaging:Article Title: The time-varying prognostic value of stenosis and plaque burden in coronary artery disease Article Snippet: .. A US Food and Drug Administration-approved artificial |
